A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Depression
NCT04211467 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-06-05
Summary
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records
Conditions
- Depression
- Clinical Depression
- Depression, Anxiety
- Depression, Postpartum
- Depression, Endogenous
- Depression in Remission
- Depression Chronic
- Depression Moderate
- Depression Severe
Interventions
- OTHER
-
No Intervention
There is no intervention for this study
Sponsors & Collaborators
-
ProgenaBiome
lead OTHER
Principal Investigators
-
Sabine Hazan, MD · ProgenaBiome
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-02
- Primary Completion
- 2030-03-31
- Completion
- 2030-07-31
Countries
- United States
Study Locations
More Related Trials
-
Neural Circuit Mechanism of Inflammatory Bowel Disease Combined With Depression
NCT06471894 ·Status: NOT_YET_RECRUITING
-
Investigation of Pathogenic Gut Microbiota Patterns in Anxiety, Depression and Panic Disorders
NCT07268729 ·Status: COMPLETED
-
Gut Microbiota in Mood Disorders in Lebanese Population
NCT05646784 ·Status: COMPLETED ·Phase: NA
-
The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients
NCT05972317 ·Status: RECRUITING ·Phase: NA
-
Microbiome, Anxiety and Cognitive Orientation Study
NCT05388630 ·Status: UNKNOWN
-
Pathophysiological Effects of Persistently Colonized Microbiome on Irritable Bowel Syndrome
NCT06013410 ·Status: RECRUITING ·Phase: NA
-
Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder
NCT01337609 ·Status: TERMINATED ·Phase: PHASE4
-
Small Intestinal Bacterial Overgrowth: A Prospective Registry
NCT01822470 ·Status: ENROLLING_BY_INVITATION
-
Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT05509725 ·Status: RECRUITING ·Phase: PHASE4
-
The Efficacy and Safty of FMT in Patients With CID
NCT05917379 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Microbiome Sampling in GI Disease With a Focus on Small Intestinal Microbial Assessment
NCT06066866 ·Status: NOT_YET_RECRUITING
-
Fecal Microbiota Transplantation for IBS
NCT05776914 ·Status: RECRUITING ·Phase: PHASE2
-
The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome
NCT04422327 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Analysis of Differences in Small Intestinal Microbiota Structure and Metabolites Between Patients With Irritable Bowel Syndrome and Healthy Individuals
NCT07212569 ·Status: NOT_YET_RECRUITING
-
The Gut-Brain Study
NCT03426826 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Gut Microbiota in Chronic GI Diseases
NCT06532110 ·Status: RECRUITING
-
Efficacy and Safety of FMT for the Treatment of IBS-D and Mental Health Comorbidity in Young Adults
NCT06297421 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Colonoscopic Probiotics Infusion for Functional Gastrointestinal Disease
NCT05366335 ·Status: UNKNOWN ·Phase: PHASE4
-
Brain-Gut-Microbiota Interaction in IBS
NCT04296552 ·Status: UNKNOWN ·Phase: NA
-
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
NCT03687814 ·Status: RECRUITING ·Phase: NA
-
The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study
NCT01412372 ·Status: COMPLETED ·Phase: PHASE3
-
Detection of Luminal and Mucosa-associated Microbiome in Healthy Controls vs. Local and Systemic Inflammation
NCT03157687 ·Status: COMPLETED
-
The Diversity of Intestinal Microbiota in Patients With Different Sedative-hypnotics Undergoing Mechanical Ventilation
NCT03401736 ·Status: WITHDRAWN ·Phase: NA
-
Changes in Microbiota and Quality of Life in IBS
NCT05266287 ·Status: UNKNOWN ·Phase: NA
-
Fecal Microbiota Transplantation in Irritable Bowel Syndrome With Bloating
NCT02299973 ·Status: COMPLETED ·Phase: NA